Where early enthusiasm around IDMP programmes had waned in response to slow progress from EMA in Europe towards clarifying ...

Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start" with more than 3,500 healthcare ...

The FDA previously designated the ADC as a breakthrough drug for relapsed or refractory extensive-stage small-cell lung ...

Now, in 2025, we expect the life sciences industry will scale its use of GenAI with greater purpose. As these applications ...

According to the US regulator, the use of AI in drug development and in regulatory submissions has "exponentially increased" ...

The result is another major disappointment to ALS patients, who have limited drug treatment options at present, particularly ...

The unidentified man is one of 66 confirmed human cases of H5N1 bird flu in the US since 2024, when the current outbreak took ...

1. Proactively identify barriers to medication adherence, including identifying and targeting patients who may be ...

Fortunately, my home isn't too far from Stamford Bridge stadium, making it easy to catch the action live! Connect with Peter ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi ...

In a statement, Neumora revealed that the KOASTAL-1 study missed its primary endpoint, with navacaprant failing to achieve a ...

NeOnc has two products in development, namely NEO100 – a purified form of perillyl acid (POH) that is administered to brain ...